Miami Cancer Institute Names Minesh ...

Dr. Minesh Mehta, MD

Claim this profile

Miami Cancer Institute

Studies Brain Tumor
Studies Meningioma
5 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.
Miami Cancer Institute
Image of trial facility.
University Of Maryland Medical Center

Clinical Trials Minesh Mehta, MD is currently running

Image of trial facility.

Radiation Therapy vs Observation

for Meningioma

This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Electric Field Therapy + Bevacizumab

for Meningioma

The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therapy has on meningiomas. Bevacizumab is considered investigational because the US Food and Drug Administration (FDA) has not approved its use for the treatment of meningiomas. The study drug is a medication that blocks the growth of new blood vessels. It is thought that the study drug may interfere with the growth of new blood vessels and therefore might stop tumor growth, and possibly shrink the tumor by keeping it from receiving nutrients and oxygen supplied by the blood vessels. Optune is also considered investigational because the US FDA has not approved its use for the treatment of meningiomas. Optune is a device that the patient will wear and use for at least 18 hours of each day. It delivers alternating electrical current to the patient's brain tumor and by doing so interrupts a process called mitosis. Mitosis needs to occur in order for cell division to occur and allows tumors to grow. By slowing this process, we hypothesize that meningioma growth may also be slowed.
Recruiting1 award Phase 212 criteria

More about Minesh Mehta, MD

Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Minesh Mehta, MD has experience with
  • Clinical Observation
  • Radiation Therapy
  • Hippocampal Avoidance
  • Whole-Brain Radiation Therapy
  • High Dose Radiation 100 CGy
  • Low Dose Radiation 35 CGy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Minesh Mehta, MD specialize in?
Is Minesh Mehta, MD currently recruiting for clinical trials?
Are there any treatments that Minesh Mehta, MD has studied deeply?
What is the best way to schedule an appointment with Minesh Mehta, MD?
What is the office address of Minesh Mehta, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security